Zhuyu Tongmai Jiaonang (逐瘀通脉胶囊)逐瘀通脉胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 哈药集团三精千鹤制药有限公司Chinese legal name: 哈药集团三精千鹤制药有限公司
主要成分Active Ingredients
- 水蛭Shui Zhi
- 桃仁Tao Ren
- 虻虫Meng Chong
- 大黄Da Huang
药物知识说明
水蛭是一种在国家药监局注册认定的药品。该药品含有大黄、桃仁、水蛭-d585206e等成分。
该药品关联的活性成分包括：大黄Da Huang、桃仁Tao Ren、水蛭Shui Zhi、虻虫Meng Chong。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：哈药集团三精千鹤制药有限公司Chinese legal name: 哈药集团三精千鹤制药有限公司。
您可以探索含有相同成分的其他药品：大黄-9694f9cc成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 逐瘀通脉胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 大黄Da Huang, 桃仁Tao Ren, 水蛭Shui Zhi, 虻虫Meng Chong.
Manufacturers recorded for this product: 哈药集团三精千鹤制药有限公司Chinese legal name: 哈药集团三精千鹤制药有限公司.
Explore other medicines containing the same ingredient: 大黄 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 逐瘀通脉胶囊Recorded Chinese name: 逐瘀通脉胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.2g*24粒0.2 g × 24 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 哈药集团三精千鹤制药有限公司Chinese legal name: 哈药集团三精千鹤制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20000138
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20000138
Manufacturer
Chinese legal name: 哈药集团三精千鹤制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.2 g × 24 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字Z20000138
生产企业
哈药集团三精千鹤制药有限公司(国产)
功能主治
破血逐瘀、通经活络。主治血瘀型眩晕证，症见眩晕、头痛耳鸣、舌质暗红、脉沉涩。
用法用量
口服。一次2粒，每日3次，4周为一疗程。
不良反应
少数病例有轻微恶心及上腹不适，一般可自行缓解。
禁忌
孕妇及有出血倾向者忌用。
注意事项
素体虚及体虚便溏者慎用，本品宜在医生指导下使用。
贮藏
密封，阴凉（不超过20℃）干燥处贮藏。
规格
0.2g*24粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.